Profile
Carrie L.
Bourdow is currently the Chairman & Chief Executive Officer at Trevena, Inc. She previously served as an Independent Director at Sesen Bio, Inc. from 2020 to 2023 and at Nabriva Therapeutics Plc from 2017 to 2023.
Prior to that, she was the Vice President-Marketing at Cubist Pharmaceuticals LLC from 2013 to 2015.
Ms. Bourdow holds an undergraduate degree from Hendrix College and an MBA from Southern Illinois University.
Carrie Bourdow active positions
| Companies | Position | Start |
|---|---|---|
| TREVENA, INC. | Chief Executive Officer | 2018-09-30 |
Former positions of Carrie Bourdow
| Companies | Position | End |
|---|---|---|
| NABRIVA THERAPEUTICS PLC | Director/Board Member | 2023-07-29 |
| CARISMA THERAPEUTICS, INC. | Director/Board Member | 2023-03-06 |
| CUBIST PHARMACEUTICALS INC | Sales & Marketing | 2015-04-30 |
Training of Carrie Bourdow
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Hendrix College
Hendrix College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Southern Illinois University
Southern Illinois University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trevena, Inc.
Trevena, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by central nervous system | Health Technology |
Sesen Bio, Inc.
Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
Nabriva Therapeutics Plc
Nabriva Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the research, development, and commercialization of novel anti-infective agents | Health Technology |
- Stock Market
- Insiders
- Carrie Bourdow
















